Biospecimen and Biomarker Specialist Adds Next-Generation Capability of OLINK® EXPLORE HT
HUNTSVILLE, Ala., Oct. 05, 2023 /PRNewswire/ — Discovery Life Sciences (Discovery), the Biospecimen and Biomarker Specialists, today announced it has expanded its high-throughput proteomics services with the addition of Olink® Explore HT. A next-generation proteomics solution, the new Olink Explore HT platform achieves greater precision and speed—enhancing Discovery’s position as a comprehensive provider of proteomics and multi-omic services.
- Deepening biological insights for a nuanced understanding of disease mechanisms.
- Enhancing biomarker discovery for pre-clinical development and clinical trials.
- Powering high-throughput proteomic analysis for population-scale health studies.
To learn more about Discovery’s proteomic services capabilities, please visit https://www.dls.com/biomarker-services/proteomics.
About Discovery Life Sciences
Through AllCells, our cell and gene therapy brand, we maintain a substantial recallable donor pool, supplying Research Use Only (RUO) and clinical-grade fresh and cryopreserved human cellular materials to support cell and gene therapy programs at any phase of development and scale.
Motivated by leading scientific expertise and innovative application of current technologies, the Discovery team collaborates with customers to rapidly overcome obstacles and achieve results, aiding in making critical research and development decisions with unparalleled speed. We are Science at your Service! For more information, visit www.dls.com.
